Vaccine News and Research

Latest Vaccine News and Research

Serum Institute signs licensing agreement to commercialize St. Jude vaccine against RSV

St. Jude Children's Research Hospital and the Serum Institute of India have signed a licensing agreement to complete development and commercialization of a St. Jude vaccine against the respiratory syncytial virus (RSV), the virus that causes croup and lower respiratory infections. RSV kills about 160,000 people, primarily infants, worldwide each year.

10 May 2017

Mothers infected with malaria during pregnancy can alter infants’ immunity

Mothers infected with malaria during pregnancy can pass more of their own cells to their baby and change the infant's risk of later infection, a new study shows.

9 May 2017

Maternal education can act as 'social vaccine' for childhood malaria infection, study finds

Every two minutes, a child will die from malaria in Africa. It is a preventable, treatable disease, that each year affects approximately 200 million people globally.

9 May 2017

New research could lead to improved therapies for global parasitic disease

Recently published research from Iowa State University biomedical scientists details new methods for studying a parasitic nematode that sickens millions worldwide, a development that could lead to improved therapies.

9 May 2017

New UCI Malaria Initiative aims to disrupt deadly disease transmission in Africa

University of California, Irvine vector biologist Anthony James will lead a multimillion-dollar effort to cultivate new strains of mosquitoes to fight malaria in Africa.

9 May 2017

Secondhand smoke may have different effects on men and women, Amish community research finds

New research at the University of Maryland School of Medicine has found that secondhand smoke tends to have somewhat different effects on men and women.

5 May 2017

Computational analysis highlights potential economic burden of Zika outbreak in the U.S.

Even a relatively mild Zika outbreak in the United States could cost more than $183 million in medical costs and productivity losses, suggests a computational analysis led by Johns Hopkins Bloomberg School of Public Health researchers, while a more severe one could result in $1.2 billion or more in medical costs and productivity losses.

3 May 2017

Study suggests how existing and emerging immunotherapy treatments could be successful for sarcomas

Sarcomas- cancers of the connective tissues like muscles, joints, fat and bone - come in dozens of subtypes. Clinical trial results have been mixed when treating these diverse tumors with immunotherapy, a targeted therapeutic strategy that has success in other cancers.

3 May 2017

Mayo Clinic scientists develop novel nanoparticle to shrink tumors, prevent breast cancer recurrence

A Mayo Clinic research team has developed a new type of cancer-fighting nanoparticle aimed at shrinking breast cancer tumors, while also preventing recurrence of the disease.

2 May 2017

Scientists rewire mouse stem cells to fight inflammation caused by arthritis

Using new gene-editing technology, researchers have rewired mouse stem cells to fight inflammation caused by arthritis and other chronic conditions.

28 Apr 2017

Early blood test can predict vaccine immunogenicity

Within seven days of vaccination, a blood test early after vaccination can predict whether vaccines based on living, modified viruses have had the desired effect.

26 Apr 2017

WHO/AFRO: Ghana, Kenya, and Malawi to participate in malaria vaccine pilot program

The World Health Organization Regional Office for Africa announced today that Ghana, Kenya, and Malawi will take part in a WHO-coordinated malaria vaccine implementation programme (MVIP) that will make the world’s first malaria vaccine available in selected areas, beginning in 2018.

26 Apr 2017

Study identifies expression of tumor antigen as marker for aggressive ovarian cancer

Patients who expressed the tumor antigen NY-ESO-1 had more aggressive cancers and were more likely to die early from their disease, according to a large study conducted by Roswell Park Cancer Institute researchers and published online ahead of print in the journal Gynecologic Oncology.

26 Apr 2017

UC Santa Cruz researcher identifies major gaps that must be filled in to control Lyme disease

Scientists have built a large body of knowledge about Lyme disease over the past 40 years, yet controversies remain and the number of cases continues to rise.

25 Apr 2017

Synthetic scaffold loaded with cancer-fighting T cells effectively shrinks solid tumors

Cellular therapy hasn't had much success in fighting solid tumors, partly because it's been difficult to deliver anti-cancer T cells to the tumors.

25 Apr 2017

UTSW researchers develop new nanoparticle vaccine immunotherapy that targets multiple tumor types

Researchers from UT Southwestern Medical Center have developed a first-of-its-kind nanoparticle vaccine immunotherapy that targets several different cancer types.

24 Apr 2017

Pregnant women’s financial strain linked to low-birth-weight infants

A financially strapped pregnant woman's worries about the arrival and care of her little one could contribute to birth of a smaller, medically vulnerable infant, a new study suggests.

24 Apr 2017

WHO drive for increased efforts to prevent malaria

WHO drive for accelerated development efforts to save lives, An event in Nairobi on the eve of World Malaria Day, sees the World Health Organization push for increased efforts to save lives through malaria prevention.

24 Apr 2017

Tiny silica 'cages' could help store and transport vaccines without refrigeration

Vaccines and antibodies could be transported and stored without refrigeration by capturing them in tiny silica 'cages', a discovery which could make getting vital medicines to remote or dangerous places much easier, cheaper and safer.

24 Apr 2017

UC San Diego Amazonian Center to receive NIH funding for malaria research

The Amazonian Center of Excellence for Malaria Research, headed by Joseph Vinetz, MD, professor of medicine and tropical disease specialist at University of California San Diego School of Medicine, will receive up to approximately $8.3 million over seven years from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

21 Apr 2017

Vaccine News and Research

Latest Vaccine News and Research

Serum Institute signs licensing agreement to commercialize St. Jude vaccine against RSV

Mothers infected with malaria during pregnancy can alter infants’ immunity

Maternal education can act as 'social vaccine' for childhood malaria infection, study finds

New research could lead to improved therapies for global parasitic disease

New UCI Malaria Initiative aims to disrupt deadly disease transmission in Africa

Secondhand smoke may have different effects on men and women, Amish community research finds

Computational analysis highlights potential economic burden of Zika outbreak in the U.S.

Study suggests how existing and emerging immunotherapy treatments could be successful for sarcomas

Mayo Clinic scientists develop novel nanoparticle to shrink tumors, prevent breast cancer recurrence

Scientists rewire mouse stem cells to fight inflammation caused by arthritis

Early blood test can predict vaccine immunogenicity

WHO/AFRO: Ghana, Kenya, and Malawi to participate in malaria vaccine pilot program

Study identifies expression of tumor antigen as marker for aggressive ovarian cancer

UC Santa Cruz researcher identifies major gaps that must be filled in to control Lyme disease

Synthetic scaffold loaded with cancer-fighting T cells effectively shrinks solid tumors

UTSW researchers develop new nanoparticle vaccine immunotherapy that targets multiple tumor types

Pregnant women’s financial strain linked to low-birth-weight infants

WHO drive for increased efforts to prevent malaria

Tiny silica 'cages' could help store and transport vaccines without refrigeration

UC San Diego Amazonian Center to receive NIH funding for malaria research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

Newsletters you may be interested in